What is an Anti-LC1 test?
The Anti-LC1 test is a blood test that detects autoantibodies against liver cytosol type 1 (LC1).
Anti-LC1 antibodies are associated mainly with autoimmune hepatitis (AIH), particularly type 2 autoimmune hepatitis. They are directed against a liver enzyme called formiminotransferase cyclodeaminase (FTCD).
Autoimmune hepatitis occurs when the immune system mistakenly attacks liver cells, causing inflammation and potentially progressive liver damage.
Anti-LC1 is considered a specific but relatively uncommon marker of autoimmune hepatitis and is usually interpreted together with other autoimmune liver antibodies and laboratory findings.
What is the Anti-LC1 test used for?
The test may be used to:
Support the diagnosis of autoimmune hepatitis
Help investigate unexplained liver inflammation or elevated liver enzymes
Provide additional information when autoimmune liver disease is suspected
Help characterize the autoimmune antibody profile in patients being evaluated for autoimmune hepatitis
Anti-LC1 is commonly assessed together with other markers such as:
ANA – antinuclear antibodies
SMA/ASMA – smooth muscle antibodies
Anti-LKM-1 – liver-kidney microsomal type 1 antibody
Anti-SLA/LP – soluble liver antigen/liver-pancreas antibody
AMA – antimitochondrial antibodies
Total IgG
Why do I need an Anti-LC1 test?
Your healthcare provider may request this test if you have laboratory or clinical findings suggesting autoimmune liver disease, such as:
Persistently elevated ALT or AST
Unexplained liver inflammation
Elevated total IgG
Jaundice
Fatigue
Abdominal discomfort
Abnormal liver function tests
Suspected autoimmune hepatitis
The test may be particularly useful when other autoimmune liver antibodies are negative but autoimmune hepatitis remains a clinical possibility.
What happens during the test?
A small blood sample is collected from a vein in your arm.
The serum is tested using an immunological method to detect antibodies against liver cytosol type 1 (LC1/FTCD).
Depending on the laboratory method, the result may be reported as Positive/Negative, Detected/Not detected, or as a numerical antibody value with a laboratory-specific cutoff.
Will I need to do anything to prepare?
Usually, no fasting or special preparation is required.
Tell your healthcare provider about any liver disease, autoimmune disease, medications, or previous laboratory results that may be relevant to the evaluation.
Are there any risks?
The test involves a routine blood collection. You may experience minor discomfort, bruising, or tenderness at the collection site.
Serious complications are very uncommon.
What do the results mean?
Positive result
A positive Anti-LC1 result means that antibodies against liver cytosol type 1 were detected.
Anti-LC1 is associated with autoimmune hepatitis, particularly the type 2 autoimmune hepatitis pattern, and can provide supportive evidence when the clinical and laboratory findings are compatible.
However, a positive result does not by itself diagnose autoimmune hepatitis.
The result should be evaluated together with:
ALT and AST
Bilirubin and other liver tests
Total IgG
Other autoimmune liver antibodies
Clinical symptoms and medical history
Imaging studies when appropriate
Liver biopsy, when clinically indicated
Anti-LC1 may occur together with anti-LKM-1, although the antibody profile can vary between patients.
Negative result
A negative Anti-LC1 result means that antibodies against LC1 were not detected by the assay.
This does not completely exclude autoimmune hepatitis.
Autoimmune hepatitis can occur without Anti-LC1 antibodies, and other autoantibodies such as ANA, SMA, anti-LKM-1, or anti-SLA/LP may be present instead.
Therefore, a negative Anti-LC1 result should not be interpreted as evidence that autoimmune hepatitis is absent when other clinical and laboratory findings remain suggestive.
Important note about the results
Anti-LC1 is a supportive marker, not a stand-alone diagnostic test for autoimmune hepatitis.
Anti-LC1 has relatively high specificity for autoimmune hepatitis but is found in only a proportion of patients. Its detection can be particularly helpful in the evaluation of type 2 autoimmune hepatitis, especially when interpreted alongside anti-LKM-1 and other findings.
A positive result should always be interpreted together with liver enzyme levels, IgG concentration, other autoantibodies, clinical history, and, when necessary, liver histology.
The exact interpretation and positive cutoff depend on the assay method and manufacturer used by the laboratory. Results should therefore be interpreted according to the laboratory's validated reference criteria.
Prefer to talk to someone first? Contact us to book.
